The United States dominates the global oncology publications landscape, representing 31.92% of top-cited papers as of 2023. China follows with 25.38%, showing one of the highest growth rates at 8.99% year-on-year. Italy, Germany, and Japan hold significant shares, around 4-6%. Emerging markets like India and Brazil demonstrate rapid growth, marked at 12.98% and 7.64% respectively. European nations like Spain and Sweden show moderate increases, contributing to their stable positions in global rankings.
Future trends to watch include China's potential to overtake the U.S. due to its rapid growth. Continued advancements in countries like India and Brazil could shift publication dynamics further, especially if these regions enhance research infrastructures and collaborations.
Top countries in Total Number of 10% Top-Cited Scientific Publications in Oncology Share by Country (Units (Publications))
| # | 10 Countries | Percent | Last Year | YoY | 5-years CAGR | |
|---|---|---|---|---|---|---|
| 1 | 1 United States | 31.92 | 2023 | +1.69% | +2.39% | View data |
| 2 | 2 China | 25.38 | 2023 | +6.26% | +8.99% | View data |
| 3 | 3 Italy | 5.58 | 2023 | +4.75% | +8.96% | View data |
| 4 | 4 Germany | 4.32 | 2023 | +2.75% | +4.19% | View data |
| 5 | 5 Japan | 4.14 | 2023 | +3.33% | +5.39% | View data |
| 6 | 6 United Kingdom | 3.8 | 2023 | +0.31% | +2.55% | View data |
| 7 | 7 France | 3.44 | 2023 | +2.37% | +6.47% | View data |
| 8 | 8 Netherlands | 2.46 | 2023 | +2.53% | +3.35% | View data |
| 9 | 9 Canada | 2.4 | 2023 | +0.73% | +1.25% | View data |
| 10 | 10 South Korea | 2.28 | 2023 | +8.85% | +5.71% | View data |
Latest reports
US Pharmaceuticals Market Report- Q4 2024
In the fourth quarter of 2024, the US pharmaceuticals market exhibited robust growth across various segments, driven by strategic investments, regulatory advancements, and...
Japan Pharmaceuticals Market Report- Q4 2024
The Japanese pharmaceutical industry in Q4 2024 exhibits dynamic shifts driven by government policies, market demand, and strategic innovations. The continuous rise of...
Germany Pharmaceuticals Market Report- Q4 2024
The fourth quarter of 2024 presented a multifaceted landscape for the German pharmaceuticals industry, characterized by economic pressures, regulatory changes, and evolving consumer...
India Pharmaceuticals Market Report- Q4 2024
The Indian pharmaceutical industry in Q4 2024 continues to show dynamic growth, fueled by advancements in biologics and biosimilars, substantial export activities, and...
UK Pharmaceuticals Market Report- Q4 2024
The UK Pharmaceuticals market in Q4 2024 faced a dynamic landscape shaped by economic, regulatory, and competitive factors. Amidst inflationary pressures and evolving...
France Pharmaceuticals Market Report- Q4 2024
The French pharmaceuticals market in the fourth quarter of 2024 was marked by significant developments across various segments, including biopharmaceuticals, generic drugs, over-the-counter...
Canada Pharmaceuticals Market Report- Q4 2024
In the fourth quarter of 2024, the Canadian pharmaceuticals market showcased dynamic growth and adaptation across various segments. The evolving landscape was influenced...
Brazil Pharmaceuticals Market Report- Q4 2024
The Brazil pharmaceuticals market in Q4 2024 is characterized by significant trends and strategic developments across various segments. The demand for generic pharmaceuticals...
Italy Pharmaceuticals Market Report- Q4 2024
The fourth quarter of 2024 presents a dynamic landscape for the pharmaceuticals market in Italy, characterized by significant trends and strategic developments across...
South Korea Pharmaceuticals Market Report- Q1 2025
The first quarter of 2025 has been pivotal for the pharmaceuticals industry in South Korea, marked by significant growth in the biopharmaceuticals and...
